Advanced Medical Solutions Grp PLC Holding(s) in Company (0398K)
December 23 2015 - 6:10AM
UK Regulatory
TIDMAMS TIDMAV.
RNS Number : 0398K
Advanced Medical Solutions Grp PLC
23 December 2015
For filings with the FCA
include the annex
For filings with issuer exclude
the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
---------------------------------------------------------------------------------------------------------
1. Identity of the issuer or Advanced Medical Solutions
the underlying issuer Group plc
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- --------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
-------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
-------------------------------------------------------------------------------------------------------
Other (please CHANGE IN NATURE : RETURN OF LOANED
specify): SHARES
----------------------------------------------------------- ------------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- ------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
BNY Norwich Union Nominees
Limited 447,817*
Chase (GA Group) Nominees
Limited 5,954,409*
Available on Request 43,500*
* denotes direct interest
------------------------------------------------------------- ------------------------------------------
5. Date of the transaction 21 December 2015
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- ------------------------------------------
6. Date on which issuer 22 December 2015
notified:
------------------------------------------------------------- ------------------------------------------
7. Threshold(s) that is/are <3% to >3% Change at Direct
crossed or Interest Level (Box 8A)
reached: (vi, vii)
------------------------------------------------------------- ------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
--------------- --------------------------- ----------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
--------------- -------------- ----------- ----------- -------------------------- -----------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------- -------------- ----------- ----------- ---------- -------------- ------- --------------
Ordinary
Shares
Not Not
GB0004536594 8,274,844* 8,274,844* 6,445,726 6,445,726 Disclosable 3.09% Disclosable
-------------- ----------- ----------- ---------- -------------- ------- --------------
* Includes Right to Recall Loaned Shares (2,009,118)
--------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
--------------- -------------- ------------------------ -------------------------- -----------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------- ---------- ------------ ------------- -------------------- ----------------
RIGHT TO N/A N/A N/A 1,829,118* Nominal Delta
RECALL LOANED
SHARES *Direct Interest
------------------- ---------- ------------ ------------- -------------------- -------- ------
0.87%
------------------------------------------------------------------------------ -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
8,274,844 3.96%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited and Friends Provident
International Limited, with the following chain of controlled
undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Life Holdings UK Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Friends Life FPG Limited (wholly owned subsidiary of
Aviva Life Holdings UK Limited)
* Friends Life FPL Limited (wholly owned subsidiary of
Friends Life FPG Limited)
* Friends Life Limited (wholly owned subsidiary of
Friends Life FPL Limited)
* Friends Life and Pensions Limited (wholly owned
subsidiary of Friends Life Limited)
* Friends Provident International Limited (wholly owned
subsidiary of Friends Life and Pensions Limited)
---------------------------------------------------------------
Proxy Voting:
-------------------------------------------------------------------------
December 23, 2015 06:10 ET (11:10 GMT)
10. Name of the proxy holder: See Section 4
------------------------------------- ----------------------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------- ----------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------- ----------------------------------
13. Additional information: Figures are based on a total
number of voting rights of
208,901,173 as per the Company's
Total Voting Rights Announcement
of 30 November 2015.
------------------------------------- ----------------------------------
14. Contact name: Neil Whittaker, Aviva plc
------------------------------------- ----------------------------------
15. Contact telephone number: 01603 684420
------------------------------------- ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUORARVBAUUAA
(END) Dow Jones Newswires
December 23, 2015 06:10 ET (11:10 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024